NIH-funded research NIH-funded research

Personalized treatment testing for Black and Hispanic children with advanced cancer in Miami

Official title: Adopting a functional precision medicine approach to reduce cancer disparities in Hispanic and Black children of Miami

Funded at Florida International University · NIH-11367285 · Data updated 2026-11-12

This program uses tumor-based lab tests plus explainable AI to find safer, personalized drug options for children with relapsed, refractory, or rare cancers, focusing on Black and Hispanic kids in Miami.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionFlorida International University
NIH-funded
Lab location1 site (Miami, United States)
Project startSeptember 20, 2017
Project endMay 31, 2027
Funding year2025
Award (this year)$359,562
NIH project number5U54MD012393-09
Project IDNIH-11367285 on NIH RePORTER

Who could benefit from this research

Could help

Pediatric patients (children) with relapsed, refractory, or rare cancers—especially Black and Hispanic children in the Miami area who have exhausted standard treatments—are the intended candidates.

Less likely to help

Children whose tumors cannot be grown or tested in the lab, or those needing immediate standard-of-care therapy, may not benefit from this program.

What this research studies

If my child enrolls, the team will combine detailed genetic and RNA profiling with high-throughput drug testing on live tumor cells taken from the child to see which drugs the tumor is sensitive to. An explainable AI tool will help interpret the lab results and prioritize treatment options that may work and have lower toxicity. The program aims to give individualized, actionable treatment recommendations for kids who have exhausted standard therapies. The effort also focuses on expanding access for Hispanic and Black children in the Miami area.

Why it matters

Potential benefit: Could identify effective, lower-toxicity, personalized treatments that improve cancer response and reduce side effects for children who have few standard options left.

How similar studies have gone: Related functional precision medicine and genomic profiling programs have shown promise in identifying actionable treatments, though prospective benefits in relapsed pediatric cancers are still being established.

Where this research is happening

  • Florida International University
    Miami, United States
    Active

Researchers

  • Principal investigator: Azzam, Diana — Florida International University
  • Study coordinator: Azzam, Diana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.